Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Skin cancer is the most common cancer in the U.S., with risks influenced by factors like sun exposure, skin type, and income.

Shares of LianBio (NASDAQ:LIAN – Get Free Report) traded down 2.1% during mid-day trading on Friday . The company traded as low as $0.20 and last traded at $0.20. 14,001 shares were traded during ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Arvinas (ARVN), 924% surge in interest Janux Therapeutics ...

A Wakefield woman who survived cancer will host a showbusiness gala in the city to raise money for the charities that helped ...

Analysts are intrested in these 5 stocks: ( ($BEAM) ), ( ($U) ), ( ($CKPT) ), ( ($INUV) ) and ( ($OCUL) ). Here is a ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

Most cells in the body send out little messengers called extracellular vesicles that carry proteins, lipids, and other ...

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...